SCRIP: Scholarly Research In Progress 2021

Page 76

Scholarly Research In Progress • Vol. 5, November 2021

A Review of the Literature: How Intestinal Microbiota Shape the Immune System and the Related Impact on Human Health and Autoimmune Disease Shane P. Bross1† Geisinger Commonwealth School of Medicine, Scranton, PA 18509 Doctor of Medicine Program Correspondence: sbross@som.geisinger.edu

1 †

Abstract The symbiotic relationship between gut microbiota and surrounding tissue significantly influences the functioning of our immune system. This review examines the current understanding of how gut microbiota contribute to shaping the immune system by influencing immune system related cells in the surrounding environment. Additionally, it examines how gut microbiota can impact human health by contributing to both intestinal and non-intestinal autoimmune diseases. The microbiota-host interaction is explored by emphasizing the evolutionary and ecological mechanisms which established their relationship; further, how gut microbiota shape the immune system and contribute to autoimmune disease generation via dysbiosis and generation of metabolic byproducts is discussed. To summarize the current understanding of the research topic we searched the PubMed database using combinations of relevant key words (e.g., “microbiome”, “immune system”, “autoimmune”), time limiters of 5 and 10 years, and ancestry technique. A comprehensive understanding of gut microbiota and their impact on the immune system elucidates disease process, mechanism, and associated symptoms. In conclusion, this understanding translates to practicing improved investigative technique, which limits waste and maximizes utility of resources. Judicious experimental design and execution fosters production of safer, more efficacious medical therapies and treatments for relevant autoimmune diseases and symptom management.

Introduction There are roughly 7.5 billion people on Earth, and each one of us is unique in one way or another. When one thinks of the word unique as it applies to people, one often thinks of a person’s hair color, eye color, personality, DNA, fingerprints, and the like. However, every person is also unique in the way that they house a different population of nearly 100 trillion microorganisms in their gut that make up their individual gut microbiomes (1). These microbes occupy niches within the human host gut, presenting potential pathogens with a survival challenge: They make it difficult for the pathogen to survive and thrive in the already occupied environment (1). As such, microbial community structure is considered a factor that can influence disease presentation, occurrence, and severity depending on the host. Perhaps the most focused area of study between the human host, its microscopic occupants, and disease is how individual microbiota populations play a role in shaping the immune system.

74

The effects that intestinal microbiota have on the immune system paves the path that leads to discussion of how these bacteria have the potential to elicit autoimmune diseases. Inflammatory bowel disease (IBD) is a result of autoimmunogenic mechanism. Crohn’s disease and ulcerative colitis are the two primary forms of IBD; both are relapsing disorders characterized by chronic inflammation in regions of the intestinal tract (2). IBD is found globally, with the highest reported prevalence in Europe (Norway and Germany) and North America (USA and Canada). Additionally, since 1990, the incidence rates for Crohn’s disease and ulcerative colitis have been rising in newly industrialized countries in Africa, Asia, and South America (3). Furthermore, gut microbiota can influence devastating non-intestinal autoimmune diseases. One of the most profound examples is multiple sclerosis. Multiple sclerosis is the most frequently seen demyelinating disease in which the immune system attacks the protective coverings of nerve cells. It has a prevalence rate of nearly 100 per 100,000 people in North America and Europe (4). In addition to addressing the connection between gut microbiota and intestinal related autoimmune diseases (IRADs), this review will explore the less-investigated connection between gut microbiota and their potential impact on nonIRADs. Exploring these relationships allows for better understanding of the potential mechanisms that contribute to disease presentation and severity. Utilizing this knowledge, the following review will also discuss potential therapies and areas of study that could be further investigated to aid in improved control and management of multiple autoimmune diseases. By first taking an ecological and evolutionary look into the relationship between human and microbe interaction, one can explore how diversity of these bacterial populations came to be by interacting with the host. Building off this foundational framework, this review investigates how this interaction shapes the immune system of the host, contributing to autoimmune disease manifestation. The ultimate purpose of this literature review is to help gain insight and understanding on how gut bacterial populations shape the immune system and contribute to disease by elucidating connections between human host and microbe relationships.

Methods A comprehensive literature review was conducted. This extensive literature search was carried out by utilizing the PubMed database, allowing for the review and collection of relevant subject content. The content analyzed includes


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Cover art submissions

1min
pages 263-264

Finding your way

1min
page 261

Medical Research Honors Program

1min
page 262

Summer Research Immersion Program

1min
page 260

Investigating Potential Conflicts of Interest

15min
pages 255-259

Differences in Multiple and Single-Drug Arrests by the Maine Diversion Alert Program (DAP)

19min
pages 250-254

A Novel Approach to Chest Wall Reconstruction Following Intrathoracic Scapular Dislocation

6min
pages 248-249

Pronounced Declines in Licit Fentanyl Utilization and Changes in Prescribing and Reimbursement Practices in the United States, 2010-2019

24min
pages 239-247

Racial Differences in Insurance Type between Diabetes Mellitus Type 2 Patients in the United States

15min
pages 235-238

The Relationship Between Treatment Center Services and Number of Opioid- related Deaths in the United States Before and After a Declaration of a National Opioid Crisis

23min
pages 225-234

Treatment of Pediatric Lisfranc Injuries: A Systematic Review and Introduction of a Novel Treatment Algorithm

22min
pages 218-224

Electroconvulsive Therapy Uses and Its Ability to Induce Neurogenesis: A Literature Review

28min
pages 203-210

Improving the Future of the Opioid Epidemic: Methocinnamox

29min
pages 211-217

Examining Health Literacy and Health Outcomes Among United States Immigrants and Non-Immigrants

24min
pages 196-202

The Changing Use of Opioids in the U.S from 2017 to Early 2020

12min
pages 191-195

Characterizing the Behavioral and Cellular Effects of the R904S Variant of OPA1 as a Tourette Disorder Probable Risk Gene

33min
pages 176-184

Why is There a Ten-Fold Variation between States in Clozapine Usage among Medicaid Enrollees in the United States?

18min
pages 185-190

The Relationship between Food Deserts and the Prevalence of Type 2 Diabetes in Communities in Southeastern Pennsylvania

17min
pages 170-175

Review of Ketamine as a Rapid Antidepressant for Treatment- Resistant Depression

30min
pages 162-169

The Association Between Early Menarche and Gestational Diabetes: A Secondary Analysis

20min
pages 156-161

Environmental Influences on Childhood

17min
pages 143-147

Declines and Pronounced Regional Disparities in Prescription Opioids in the United States

24min
pages 148-155

The Role of Socioeconomic Factors

25min
pages 135-142

The Natural History of Genu Valgum in the Pediatric Obese Patient

15min
pages 125-129

Review of Selected Contemporary Treatments for Ischemic Stroke

20min
pages 130-134

An Examination of the Impact of COVID-19 on Black, Latino and Asian New York City Residents and the Factors Associated with the Social Determinants of Health

25min
pages 118-124

Effects of Medical Cannabis on Patients with Charcot-Marie-Tooth Disease

23min
pages 105-111

Short- and Long-Term Outcomes of Breastfeeding on Children’s Mental and Physical Health

30min
pages 112-117

Hunger vs. Heart Failure Can Food Insecurity Screening Prevent CHF Exacerbations?

12min
pages 101-104

Measuring the Change in Use of Generic Oxcarbazepine (OXC) Versus Brand Names for Medicaid Enrollees Throughout the United States in 2018-2019

19min
pages 94-100

Conflict of Interest Disclosure Accuracy

9min
pages 91-93

Exploring the Impact of Medicaid

24min
pages 84-90

A Review of the Literature: How Intestinal Microbiota Shape the Immune System and the Related Impact on Human Health and Autoimmune Disease

28min
pages 76-83

Chronic Traumatic Encephalopathy A Literature Review

32min
pages 68-75

Primary Ectopic Breast Carcinoma of the Vulva: A Case Report

11min
pages 51-54

Trends and Regional Differences in the Diversion of Stimulants in the United States, 2015–2019

17min
pages 55-60

Changes in Morphine Distribution in the United States

12min
pages 64-67

Hydroxychloroquine, Azithromycin, and Chloroquine Prescribing Patterns in Medicaid

7min
pages 61-63

Battling Trainee Biases and Reconstructing Perceptions in Global Neurology

5min
pages 49-50

Virtual Newborn Nursery Rounds: An Alternative Experience During the COVID-19 Pandemic

14min
pages 45-48

Ethics and Current Climates Surrounding HPV Vaccination

26min
pages 39-44

Rat-Bite Fever in a 14-Year-Old Male

8min
pages 18-19

Recent Trends in Gabapentin Usage Among Medicaid Patients

12min
pages 26-29

Geographic Variability in Antibiotic Prescribing Rates in Medicaid

14min
pages 7-11

Assessment and Improvement of Sepsis Bundle Compliance at Geisinger Community Medical Center

16min
pages 30-34

Conflicts of Interest Differ Among Male and

12min
pages 35-38

Preventability Associated with Elevated Maternal Mortalities Among Black Women

18min
pages 20-25

Declining National Codeine Distribution in United States Hospitals and Pharmacies

17min
pages 12-17

Pelvic Examinations Under Anesthesia (EUA) Informed Consent Policy

9min
pages 4-6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.